149
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Coagulative biomarkers on admission to the ICU predict acute kidney injury and mortality in patients with septic shock caused by intra-abdominal infection

, , , , , , , , ORCID Icon & show all
Pages 2755-2764 | Published online: 04 Sep 2019

References

  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.028726903338
  • Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369(18):1726–1734. doi:10.1056/NEJMra120894324171518
  • Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2015;43(1):3–12. doi:10.1097/CCM.000000000000072325275252
  • Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840–851. doi:10.1056/NEJMra120862323984731
  • Boldingh QJ, de Vries FE, Boermeester MA. Abdominal sepsis. Curr Opin Crit Care. 2017;23(2):159–166. doi:10.1097/MCC.000000000000038828107224
  • Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423. doi:10.1007/s00134-015-3934-726162677
  • Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58–66. doi:10.1056/NEJMra121424324988558
  • Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509–518. doi:10.1001/jama.2016.1048527483065
  • Vanmassenhove J, Kielstein J, Jorres A, Biesen WV. Management of patients at risk of acute kidney injury. Lancet. 2017;389(10084):2139–2151. doi:10.1016/S0140-6736(17)31329-628561005
  • Bellomo R, Kellum JA, Ronco C, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816–828. doi:10.1007/s00134-017-4755-728364303
  • Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter Suppl. 2012;2:1–138.
  • Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med. 2010;38(2 Suppl):S35–S42. doi:10.1097/CCM.0b013e3181c9e31d20083912
  • Perrin J, Charron C, Francois JH, et al. Coagulation phenotypes in septic shock as evaluated by calibrated automated thrombography. Shock. 2015;43(1):74–79. doi:10.1097/SHK.000000000000027125255379
  • Thiery-Antier N, Binquet C, Vinault S, Meziani F, Boisramé-Helms J, Quenot J-P. Is thrombocytopenia an early prognostic marker in septic shock? Crit Care Med. 2016;44(4):764–772. doi:10.1097/CCM.000000000000152026670473
  • Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38–44. doi:10.1016/j.thromres.2016.11.00727886531
  • Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(2 Suppl):S26–S34. doi:10.1097/CCM.0b013e3181c98d2120083910
  • Fourrier F. Severe sepsis, coagulation, and fibrinolysis: dead end or one way? Crit Care Med. 2012;40(9):2704–2708. doi:10.1097/CCM.0b013e318258ff3022732284
  • Verma SK, Molitoris BA. Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin Nephrol. 2015;35(1):96–107. doi:10.1016/j.semnephrol.2015.01.01025795503
  • de Stoppelaar SF, van ‘t Veer C, van der Poll T. The role of platelets in sepsis. Thromb Haemost. 2014;112(4):666–677. doi:10.1160/TH14-02-012624966015
  • Mihajlovic D, Lendak D, Mitic G, et al. Prognostic value of hemostasis-related parameters for prediction of organ dysfunction and mortality in sepsis. Turk J Med Sci. 2015;45(1):93–98.25790536
  • Greco E, Lupia E, Bosco O, Vizio B, Montrucchio G. Platelets and multi-organ failure in sepsis. Int J Mol Sci. 2017;18(10):2200. doi:10.3390/ijms18102200
  • Su CM, Cheng HH, Hung CW, et al. The value of serial serum cell adhesion molecules in predicting acute kidney injury after severe sepsis in adults. Clin Chim Acta. 2016;457:86–91. doi:10.1016/j.cca.2016.04.00827083317
  • Liu KL, Lee KT, Chang CH, Chen YC, Lin SM, Chu PH. Elevated plasma thrombomodulin and angiopoietin-2 predict the development of acute kidney injury in patients with acute myocardial infarction. Critical Care. 2014;18(3):R100. doi:10.1186/cc1371224886544
  • Katayama S, Nunomiya S, Koyama K, et al. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin. Critical Care. 2017;21(1):229. doi:10.1186/s13054-017-1686-128841902
  • Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect. 2010;11(1):79–109. doi:10.1089/sur.2009.9930
  • Mazuski JE, Tessier JM, May AK, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect. 2017;18(1):1–76. doi:10.1089/sur.2016.261
  • Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Critical Care. 2013;17(1):204. doi:10.1186/cc1273423394211
  • Hartwig J, Italiano J Jr. The birth of the platelet. J Thromb Haemost. 2003;1(7):1580–1586.12871294
  • Lyons PG, Micek ST, Hampton N, Kollef MH. Sepsis-associated coagulopathy severity predicts hospital mortality. Crit Care Med. 2018;46:736–742. doi:10.1097/CCM.000000000000299729373360
  • Benediktsson S, Frigyesi A, Kander T. Routine coagulation tests on ICU admission are associated with mortality in sepsis: an observational study. Acta Anaesthesiol Scand. 2017;61(7):790–796. doi:10.1111/aas.1291828681428
  • Pernerstorfer T, Hollenstein U, Hansen JB, et al. Lepirudin blunts endotoxin-induced coagulation activation. Blood. 2000;95(5):1729–1734.10688831
  • Puy C, Ngo ATP, Pang J, et al. Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) blocks the intrinsic pathway of coagulation, inducing the clearance and degradation of FXIa (Activated Factor XI). Arterioscler Thromb Vasc Biol. 2019;39(7):1390–1401. doi:10.1161/ATVBAHA.119.31261931242030
  • Aird WC. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med. 2001;29(7 Suppl):S28–S35. doi:10.1097/00003246-200107001-0001311445731
  • Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA. 2016;315(20):2190–2199. doi:10.1001/jama.2016.582827209269
  • Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Critical Care. 2011;15(1):R72. doi:10.1186/cc1032421352532
  • Meziani F, Gando S, Vincent JL. Should all patients with sepsis receive anticoagulation? Yes. Intensive Care Med. 2017;43(3):452–454. doi:10.1007/s00134-016-4621-z28194512
  • van der Poll T, Opal SM. Should all septic patients be given systemic anticoagulation? No. Intensive Care Med. 2017;43(3):455–457. doi:10.1007/s00134-016-4607-x28194511
  • Zarychanski R, Abou-Setta AM, Kanji S, et al. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015;43(3):511–518. doi:10.1097/CCM.000000000000076325493972
  • Wang C, Chi C, Guo L, et al. Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis. Critical Care. 2014;18(5):563. doi:10.1186/cc1371225318353
  • Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 2001;286(15):1869–1878. doi:10.1001/jama.286.15.186911597289
  • Wikkelso A, Wetterslev J, Moller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016;8(8):CD007871.